# GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children

> **NCT00886626** · PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 12 (actual)

## Conditions studied

- Obesity, Morbid

## Interventions

- **DRUG:** Exenatide

## Key facts

- **NCT ID:** NCT00886626
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00886626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00886626, "GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00886626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*